GENE ONLINE|News &
Opinion
Blog

2025-11-30|

SGMS2+ Macrophages Linked to Increased NR4A3hi NK Cell Infiltration in Hepatocellular Carcinoma

by GOAI
Share To

A recent study has identified a key interaction between SGMS2+ macrophages and natural killer (NK) cells that may influence prognosis and treatment outcomes in hepatocellular carcinoma (HCC). Researchers, including Meng, Nian, Feng, and their team, found that SGMS2+ macrophages play a role in enhancing the infiltration of NR4A3hi NK cells into tumor environments. This discovery could have implications for improving the efficacy of PD-1 immunotherapy in HCC patients.

The findings, published in the Journal of [details redacted], suggest that the presence of SGMS2+ macrophages correlates with increased levels of NR4A3hi NK cells within tumors. These NK cells are known for their ability to target and destroy cancerous cells. The study also highlights how this interaction may contribute to better patient prognoses and improved responses to PD-1 checkpoint inhibitor treatments. The research provides new insights into immune cell dynamics within HCC tumors and opens potential avenues for enhancing immunotherapeutic strategies.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Phosphorylation and Ubiquitination Mechanisms Linked to Rosacea Pathogenesis
2026-10-10
Malin and Goetz Updates SPF 30 Mineral Sunscreen Documentation on DailyMed
2026-10-09
Henry Schein Updates Vitamin A & D Ointment Product Documentation on DailyMed
2026-10-09
Mary Kay Updates Clear Proof Acne Treatment Gel Labeling in DailyMed Database
2026-10-09
Dechra Veterinary Products Updates Muricin Ointment Documentation on DailyMed
2026-10-09
Cardinal Health Updates LEADER Daily Moisturizer Product Documentation on DailyMed
2026-10-09
S.S.S. Company Updates Curasore Pramoxine Hydrochloride Product Information on DailyMed
2026-10-09
EVENT
Scroll to Top